The forecast for the veterinary vaccines market in Canada, excluding foot-and-mouth disease vaccines, shows a gradual decline in market size from 283.98 million USD in 2024 to 277.82 million USD in 2028. Compared to the actual market size in 2023, which stood at an estimated 286.5 million USD, this reflects a consistent year-on-year decrease in value, averaging around -0.56% annually over the forecast period, indicating a slight negative compounded annual growth rate (CAGR) over these five years.
Future trends to watch include potential impacts from advancements in biotechnology that may lower production costs and increase vaccine efficacy. Additionally, rising demand for preventive animal health measures and changes in regulatory environments could influence market dynamics positively or negatively, suggesting a need for firms to innovate and adapt in response to these shifts.
